|
|
||||||||



* Graduate Institute of Immunology, College of Medicine, National Taiwan University,
Department of Internal Medicine, Taipei Ho-Ping Municipal Hospital, and
Hepatitis Research Center and
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; and
¶ Department of Internal Medicine, Veterans General Hospital-Kaohsiung, Kaohsiung, Taiwan
Hepatitis C virus (HCV) is a major human pathogen causing chronic liver disease, which leads to cirrhosis of liver and hepatocellular carcinoma. The HCV core protein, a viral nucleocapsid, has been shown to affect various intracellular events, including cell proliferation and apoptosis. However, the precise mechanisms of the effects are not fully understood. In this study, we show that HCV core protein sensitizes human hepatocellular carcinoma cell line, Huh7, conferred sensitivity to TRAIL-, but not Fas ligand-mediated apoptosis. Huh7 cells are resistant to TRAIL, despite the induction of caspase-8 after TRAIL engagement. However, HCV core protein induces TRAIL apoptosis signaling via sequential induction of caspase-8, Bid cleavage, activation of mitochondrial pathway, and effector caspase-3. HCV core protein also induces activation of caspase-9 after TRAIL engagement, and the induction of TRAIL sensitivity by HCV core protein could be reversed by caspase-9 inhibitor. Therefore, the HCV core protein-induced TRAIL-mediated apoptosis is dependent upon activation of caspase-8 downstream pathway to convey the death signal to mitochondria, leading to activation of mitochondrial signaling pathway and breaking the apoptosis resistance. These results combined indicate that the HCV core protein enhances TRAIL-, but not Fas ligand-mediated apoptotic cell death in Huh7 cells via a mechanism dependent on the activation of mitochondria apoptosis signaling pathway. These results suggest that HCV core protein may have a role in immune-mediated liver cell injury by modulation of TRAIL-induced apoptosis.
This article has been cited by other articles:
![]() |
N. K. Mohd-Ismail, L. Deng, S. K. Sukumaran, V. C. Yu, H. Hotta, and Y.-J. Tan The Hepatitis C Virus Core Protein Contains a BH3 Domain That Regulates Apoptosis through Specific Interaction with Human Mcl-1 J. Virol., October 1, 2009; 83(19): 9993 - 10006. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng, T. Adachi, K. Kitayama, Y. Bungyoku, S. Kitazawa, S. Ishido, I. Shoji, and H. Hotta Hepatitis C Virus Infection Induces Apoptosis through a Bax-Triggered, Mitochondrion-Mediated, Caspase 3-Dependent Pathway J. Virol., November 1, 2008; 82(21): 10375 - 10385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lan, S. Gorke, S. J. Rau, M. B. Zeisel, E. Hildt, K. Himmelsbach, M. Carvajal-Yepes, R. Huber, T. Wakita, A. Schmitt-Graeff, et al. Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner J. Immunol., October 1, 2008; 181(7): 4926 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gasper-Smith, D. M. Crossman, J. F. Whitesides, N. Mensali, J. S. Ottinger, S. G. Plonk, M. A. Moody, G. Ferrari, K. J. Weinhold, S. E. Miller, et al. Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design J. Virol., August 1, 2008; 82(15): 7700 - 7710. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Malhi, F. J Barreyro, H. Isomoto, S. F Bronk, and G. J Gores Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity Gut, August 1, 2007; 56(8): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, D. F. Boehning, T. Qian, V. L. Popov, and S. A. Weinman Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity FASEB J, August 1, 2007; 21(10): 2474 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-I. You, M.-C. Chen, H.-W. Wang, Y.-C. Chou, C.-H. Lin, and S.-L. Hsieh Inhibition of Lymphotoxin-{beta} Receptor-Mediated Cell Death by Survivin-{Delta}Ex3. Cancer Res., March 15, 2006; 66(6): 3051 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Lee, Y. K. Kim, C. S. Kim, S. K. Seol, J. Kim, S. Cho, Y. L. Song, R. Bartenschlager, and S. K. Jang E2 of Hepatitis C Virus Inhibits Apoptosis J. Immunol., December 15, 2005; 175(12): 8226 - 8235. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |